The present PhD Thesis is focused on the fabrication of hybrid scaffolds for bone regeneration through biomimetic mineralization of recombinant collagen peptide (RCP) in the presence of magnesium (Mg) to closely mimic ionic composition of bone apatite. RCP, produced by FUJIFILM Manufacturing Europe B.V. under tradename of CellnestTM, is based on human collagen type I and it is enriched in arginine-glycine-aspartic acid sequence (RGD), that acts as a cell binding site. Biomimetic mineralization of RCP has been adapted from the bioinspired mineralization protocol of natural collagen carried out previously by our group to obtain bone-like scaffolds. Inspired in nanocomposite nature of bone, hybrid scaffolds were developed through a bottom-up a...
Recombinant human collagen peptide, developed based on human collagen type I, contains an arginyl-gl...
Bone tissue engineering offers an alternative promising solution to treat a large number of bone in...
With an ageing world population and ~20% of adults in Europe being affected by bone diseases, there ...
Recombinant peptides have the power to harness the inherent biocompatibility of natural macromolecul...
The present work is focused on the development of gelatin-based scaffolds crosslinked through carbod...
The limitations of large bone defect regeneration has brought the focus of Bone Tissue Engineering r...
In bone tissue engineering, the design of 3D systems capable of recreating composition, architecture...
Designing biomaterials for bone-substitute applications is still a challenge regarding the natural c...
Tissue engineering offers a significant potential alternative to conventional methods for rectifying...
Cell-free translational strategies are needed to accelerate the repair of mineralised tissues, parti...
Natural bone has a complex hierarchical structure in which well-organized collagen fibrils are reinf...
Biomineralization is a complex ensemble of concomitant phenomena, driving the development of vertebr...
Collagen, the most abundant protein, and hydroxyapatite, the main component in natural bone, are usu...
Designing biomaterials for bone-substitute applications is still a challenge regarding the natural c...
Despite the demonstration of various engineered tissues, clinically useful bone tissue regeneration ...
Recombinant human collagen peptide, developed based on human collagen type I, contains an arginyl-gl...
Bone tissue engineering offers an alternative promising solution to treat a large number of bone in...
With an ageing world population and ~20% of adults in Europe being affected by bone diseases, there ...
Recombinant peptides have the power to harness the inherent biocompatibility of natural macromolecul...
The present work is focused on the development of gelatin-based scaffolds crosslinked through carbod...
The limitations of large bone defect regeneration has brought the focus of Bone Tissue Engineering r...
In bone tissue engineering, the design of 3D systems capable of recreating composition, architecture...
Designing biomaterials for bone-substitute applications is still a challenge regarding the natural c...
Tissue engineering offers a significant potential alternative to conventional methods for rectifying...
Cell-free translational strategies are needed to accelerate the repair of mineralised tissues, parti...
Natural bone has a complex hierarchical structure in which well-organized collagen fibrils are reinf...
Biomineralization is a complex ensemble of concomitant phenomena, driving the development of vertebr...
Collagen, the most abundant protein, and hydroxyapatite, the main component in natural bone, are usu...
Designing biomaterials for bone-substitute applications is still a challenge regarding the natural c...
Despite the demonstration of various engineered tissues, clinically useful bone tissue regeneration ...
Recombinant human collagen peptide, developed based on human collagen type I, contains an arginyl-gl...
Bone tissue engineering offers an alternative promising solution to treat a large number of bone in...
With an ageing world population and ~20% of adults in Europe being affected by bone diseases, there ...